UBS Group AG - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 2 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$58,000
-52.1%
254,952
-23.7%
0.00%
Q4 2021$121,000334,183
+3037927.3%
0.00%
Q3 2021$0
-100.0%
11
-99.9%
0.00%
Q2 2021$9,0008,190
+74354.5%
0.00%
Q1 2021$0110.0%0.00%
Q4 2020$0110.0%0.00%
Q3 2020$0
-100.0%
11
-98.9%
0.00%
Q2 2020$1,0001,011
+9090.9%
0.00%
Q1 2020$0110.0%0.00%
Q4 2019$0110.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 734,477$441,0000.04%
GSA CAPITAL PARTNERS LLP 516,218$310,0000.03%
Game Plan Financial Advisors, LLC 27,216$16,0000.01%
MONECO Advisors, LLC 35,000$21,0000.01%
Purus Wealth Management, LLC 15,000$9,0000.01%
Renaissance Technologies 6,038,664$3,630,0000.01%
Qube Research & Technologies Ltd 540,878$325,0000.00%
D. E. Shaw & Co., Inc. 6,690,867$4,022,0000.00%
Cutter & CO Brokerage, Inc. 19,000$11,0000.00%
Van Hulzen Asset Management, LLC 18,200$11,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders